Compassionate Use of Vidutolimod
- Registration Number
- NCT06063746
- Lead Sponsor
- Regeneron Pharmaceuticals
- Brief Summary
Provide Compassionate Use of Vidutolimob
- Detailed Description
Compassionate use is only available to patients who transitioned from a previous vidutolimod (CMP-001) study.
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Exclusion Criteria
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method